MeiraGTx MGTX Stock
MeiraGTx Price Chart
MeiraGTx MGTX Financial and Trading Overview
| MeiraGTx stock price | 5.75 USD |
| Previous Close | 7.61 USD |
| Open | 7.57 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1000 |
| Day's Range | 7.21 - 7.94 USD |
| 52 Week Range | 4.77 - 11.58 USD |
| Volume | 93.89K USD |
| Avg. Volume | 135.01K USD |
| Market Cap | 468.86M USD |
| Beta (5Y Monthly) | 1.370844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24 USD |
MGTX Valuation Measures
| Enterprise Value | 491.85M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.3296704 |
| PEG Ratio (5 yr expected) | -1.3 |
| Price/Sales (ttm) | 34.422024 |
| Price/Book (mrq) | 4.2525635 |
| Enterprise Value/Revenue | 36.11 |
| Enterprise Value/EBITDA | -4.484 |
Trading Information
MeiraGTx Stock Price History
| Beta (5Y Monthly) | 1.370844 |
| 52-Week Change | 7.65% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.58 USD |
| 52 Week Low | 4.77 USD |
| 50-Day Moving Average | 6.37 USD |
| 200-Day Moving Average | 6.95 USD |
MGTX Share Statistics
| Avg. Volume (3 month) | 135.01K USD |
| Avg. Daily Volume (10-Days) | 123.88K USD |
| Shares Outstanding | 59.5M |
| Float | 31.37M |
| Short Ratio | 9.18 |
| % Held by Insiders | 10.04% |
| % Held by Institutions | 61.46% |
| Shares Short | 1.2M |
| Short % of Float | 2.77% |
| Short % of Shares Outstanding | 2.00% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -876.44% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.91% |
| Return on Equity (ttm) | -102.52% |
Income Statement
| Revenue (ttm) | 13.62M USD |
| Revenue Per Share (ttm) | 0.3 USD |
| Quarterly Revenue Growth (yoy) | -40.79% |
| Gross Profit (ttm) | 15.92M USD |
| EBITDA | -109684000 USD |
| Net Income Avi to Common (ttm) | -128934000 USD |
| Diluted EPS (ttm) | -2.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 68.78M USD |
| Total Cash Per Share (mrq) | 1.16 USD |
| Total Debt (mrq) | 91.77M USD |
| Total Debt/Equity (mrq) | 101.72 USD |
| Current Ratio (mrq) | 1.498 |
| Book Value Per Share (mrq) | 1.853 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -102192000 USD |
| Levered Free Cash Flow (ttm) | -62528752 USD |
Profile of MeiraGTx
| Country | United States |
| State | NY |
| City | New York |
| Address | 450 East 29th Street |
| ZIP | 10016 |
| Phone | 646 860 7985 |
| Website | https://meiragtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 343 |
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
Q&A For MeiraGTx Stock
What is a current MGTX stock price?
MeiraGTx MGTX stock price today per share is 5.75 USD.
How to purchase MeiraGTx stock?
You can buy MGTX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MeiraGTx?
The stock symbol or ticker of MeiraGTx is MGTX.
Which industry does the MeiraGTx company belong to?
The MeiraGTx industry is Biotechnology.
How many shares does MeiraGTx have in circulation?
The max supply of MeiraGTx shares is 78.85M.
What is MeiraGTx Price to Earnings Ratio (PE Ratio)?
MeiraGTx PE Ratio is now.
What was MeiraGTx earnings per share over the trailing 12 months (TTM)?
MeiraGTx EPS is -2.12 USD over the trailing 12 months.
Which sector does the MeiraGTx company belong to?
The MeiraGTx sector is Healthcare.
MeiraGTx MGTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
9.99B USD — | 14784.03 USD — | 16292.28 USD — | — - | 9.99B USD — |
| NASDAQ Global Select Market Com NQGS | 7634.31 USD — |
+0.11
|
— — | 7233.89 USD — | 7972.89 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3856.67 USD — |
-1.22
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}